Professor of Molecular Toxicology, Department of Physiology and Pharmacology, Karolinska Institute, Sweden
Magnus Ingelman-Sundberg serves as Chairman of the Recruitment committee at Karolinska Institutet and is a member of The Nobel Assembly at Karolinska Institutet.
He was Chairman of the Editorial Board of Pharmacogenetics and Genomics 2005-2010 and is Chairman of the Microsomes and Drug Oxidation organisation.
He has 350 original papers, 18 700 citations and an h-factor of 74. He is ranked as the 4th most highly impact researcher of 4,000 in the field of drug metabolism (http://www.cytochrome.net ) and one of the worlds most cited authors within the category Pharmacology (http://isihighlycited.com/).
Ingelman-Sundbergs group identified the first example of stable gene duplication and gene amplification in the human genome in 1993 and identified the ultrarapid metaboliser (UM) phenotype for CYP2D6 and CYP2C19.
The current research is centered about genetic predictors for drug response and adverse drug reactions.